Treatment of Drug-resistant Tuberculosis with Bedaquiline in a High HIV Prevalence Setting: An Interim Cohort Analysis

Hdl Handle:
http://hdl.handle.net/10144/560845
Title:
Treatment of Drug-resistant Tuberculosis with Bedaquiline in a High HIV Prevalence Setting: An Interim Cohort Analysis
Authors:
Ndjeka, N; Conradie, F; Schnippel, K; Hughes, J; Bantubani, N; Ferreira, H; Maartens, G; Mametja, D; Meintjes, G; Padanilam, X; Variava, E; Pym, A; Pillay, Y
Journal:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Abstract:
South Africa has a large burden of extensively drug-resistant tuberculosis (XDR-TB); only 15% of XDR-TB patients have successful outcomes.
Publisher:
International Union Against Tuberculosis and Lung Disease
Issue Date:
1-Aug-2015
URI:
http://hdl.handle.net/10144/560845
DOI:
10.5588/ijtld.14.0944
PubMed ID:
26162365
Language:
en
ISSN:
1815-7920
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorNdjeka, Nen_GB
dc.contributor.authorConradie, Fen_GB
dc.contributor.authorSchnippel, Ken_GB
dc.contributor.authorHughes, Jen_GB
dc.contributor.authorBantubani, Nen_GB
dc.contributor.authorFerreira, Hen_GB
dc.contributor.authorMaartens, Gen_GB
dc.contributor.authorMametja, Den_GB
dc.contributor.authorMeintjes, Gen_GB
dc.contributor.authorPadanilam, Xen_GB
dc.contributor.authorVariava, Een_GB
dc.contributor.authorPym, Aen_GB
dc.contributor.authorPillay, Yen_GB
dc.date.accessioned2015-07-21T22:48:23Z-
dc.date.available2015-07-21T22:48:23Z-
dc.date.issued2015-08-01-
dc.identifier.citationTreatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. 2015, 19 (8):979-85 Int. J. Tuberc. Lung Dis.en_GB
dc.identifier.issn1815-7920-
dc.identifier.pmid26162365-
dc.identifier.doi10.5588/ijtld.14.0944-
dc.identifier.urihttp://hdl.handle.net/10144/560845-
dc.description.abstractSouth Africa has a large burden of extensively drug-resistant tuberculosis (XDR-TB); only 15% of XDR-TB patients have successful outcomes.en_GB
dc.language.isoenen
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen_GB
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung Disease : the official journal of the International Union against Tuberculosis and Lung Diseaseen_GB
dc.titleTreatment of Drug-resistant Tuberculosis with Bedaquiline in a High HIV Prevalence Setting: An Interim Cohort Analysisen
dc.identifier.journalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseaseen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.